Literature DB >> 20006802

Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes?

Michael S Conte1.   

Abstract

Lower-extremity vein bypass surgery has been a standard operation in the armamentarium of vascular surgeons for more than 4 decades. Yet there remains surprising heterogeneity in the utilization, techniques, and outcomes associated with this procedure in current practice. Despite improvements in surgical technique and careful postoperative surveillance, vein graft failure remains a significant clinical problem affecting up to 50% of patients within 5 years. Experience, clinical judgment, creativity, and technical precision are required to optimize long-term results. Many factors, including patient-specific comorbidities, and variable biologic responses in the venous conduit, influence the ultimate outcome. Technical factors, however, play a dominant role in determining clinical success. Multiple single-center reports, and more recent multicenter trials, have clearly demonstrated that conduit selection and quality is the most critical element. An adequate caliber (>/=3.5 mm), good quality great saphenous vein is the optimal graft for infrainguinal bypass. Contralateral great saphenous vein, arm vein, and lesser saphenous vein are the next most desirable conduits. Graft configuration (reversed, nonreversed, or in situ) appears to have little influence on outcomes per se. Shorter grafts have improved patency. Inflow can be improved by surgical or endovascular means if necessary, and distal-origin grafts perform as well as those originating from the common femoral artery. The selected outflow vessel should supply unimpeded runoff to the foot, conserve conduit length, and allow for adequate soft-tissue coverage of the graft and a simplified surgical exposure. This review summarizes the data linking technical factors with graft patency, highlighting the importance of surgical judgment and operative planning in the current practice of infrainguinal bypass surgery.

Entities:  

Mesh:

Year:  2009        PMID: 20006802     DOI: 10.1053/j.semvascsurg.2009.10.004

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  21 in total

1.  A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.

Authors:  Luciana B Lopes; Colleen M Brophy; Charles R Flynn; Zhengping Yi; Benjamin P Bowen; Christopher Smoke; Brandon Seal; Alyssa Panitch; Padmini Komalavilas
Journal:  J Vasc Surg       Date:  2010-09-22       Impact factor: 4.268

Review 2.  Current state of diagnosis and management of critical limb ischemia.

Authors:  Dan Clair; Samir Shah; John Weber
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

3.  Pressure control during preparation of saphenous veins.

Authors:  Fan Dong Li; Susan Eagle; Colleen Brophy; Kyle M Hocking; Michael Osgood; Padmini Komalavilas; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

4.  Neointimal hyperplasia in allogeneic and autologous venous grafts is not different in nature.

Authors:  Albert Busch; Elena Hartmann; Nicole Wagner; Süleyman Ergün; Ralph Kickuth; Richard Kellersmann; Udo Lorenz
Journal:  Histochem Cell Biol       Date:  2015-03-19       Impact factor: 4.304

5.  Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function.

Authors:  Susan Eagle; Colleen M Brophy; Padmini Komalavilas; Kyle Hocking; Gowthami Putumbaka; Michael Osgood; Kevin Sexton; Marzia Leacche; Joyce Cheung-Flynn
Journal:  Am Surg       Date:  2011-07       Impact factor: 0.688

6.  Radial artery grafts for lower limb revascularisation.

Authors:  M Griffin; A Karthikesalingam; J Brownrigg; R J Hinchliffe
Journal:  Ann R Coll Surg Engl       Date:  2014-10       Impact factor: 1.891

7.  Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.

Authors:  Igor V Voskresensky; Eric S Wise; Kyle M Hocking; Fan Dong Li; Michael J Osgood; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-11       Impact factor: 14.766

8.  Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Authors:  Joseph D Raffetto; Peng Yu; Ossama M Reslan; Yin Xia; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

Review 9.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

10.  A simplified murine intimal hyperplasia model founded on a focal carotid stenosis.

Authors:  Ming Tao; Christine R Mauro; Peng Yu; John T Favreau; Binh Nguyen; Glenn R Gaudette; C Keith Ozaki
Journal:  Am J Pathol       Date:  2012-11-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.